Miriam Bazan-peregrino
R&D Manager
Management
VCNBiosciences
Spain
Biography
Dr. Bazan-Peregrino is an expert in oncolytic virotherapy and gene therapy. She is author of many original scientific papers and reviews in peer-reviewed journals, and has presented her research work in a large number of international conferences. During her doctoral research at the University of Oxford in the UK), she was mainly concerned about genetically modifying oncolytic adenoviruses. As the Bellhouse Research Fellow by Examination in Biomedical Engineering (Magdalen College, University of Oxford), she was interested in enhancing the delivery of oncolytic virotherapy to the tumour with different techniques. As a Marie Curie Intra-European Research Fellow at IDIBELL, she was also interested in the relationships between oncolytic viruses and immune responses against the tumour. She has also worked at the Catalan Institute of Oncology (ICO). Dr. Bazan-Peregrino joined VCN Biosciences in 2014 as the R&D Manager in order to strategically plan VCN candidates at preclinical level, and manage technical staff and R&D activities.
Research Interest
Virotherapy, Gene therapy, Oncology
